Nannini, S.; Moinard-Butot, F.; Ladoire, S.; Bochaton, D.; Bigot, P.; Lefort, F.; Mahammedi, H.; Calcagno, F.; Richaud, J.-B.B.; Campedel, L.;
et al. First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer. Med. Sci. Forum 2025, 39, 2.
https://doi.org/10.3390/msf2025039002
AMA Style
Nannini S, Moinard-Butot F, Ladoire S, Bochaton D, Bigot P, Lefort F, Mahammedi H, Calcagno F, Richaud J-BB, Campedel L,
et al. First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer. Medical Sciences Forum. 2025; 39(1):2.
https://doi.org/10.3390/msf2025039002
Chicago/Turabian Style
Nannini, Simon, Fabien Moinard-Butot, Sylvain Ladoire, Dorian Bochaton, Pierre Bigot, Félix Lefort, Hakim Mahammedi, Fabien Calcagno, Jean-Baptiste Barbe Richaud, Luca Campedel,
and et al. 2025. "First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer" Medical Sciences Forum 39, no. 1: 2.
https://doi.org/10.3390/msf2025039002
APA Style
Nannini, S., Moinard-Butot, F., Ladoire, S., Bochaton, D., Bigot, P., Lefort, F., Mahammedi, H., Calcagno, F., Richaud, J.-B. B., Campedel, L., Falkowski, S., Amrane, K., Charalambous, H., Cornillon, P., & Barthélémy, P.
(2025). First Interim Analysis of the CABONEXT Study: A Retrospective Evaluation of Treatment Patterns Following Cabozantinib Treatment for Advanced Renal Cancer. Medical Sciences Forum, 39(1), 2.
https://doi.org/10.3390/msf2025039002
